HBV-IN-19 TFA

CAT: 0931-T63937-01Size: 25 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0931-T63937-01Size:25 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

CAS Number

2241575-60-8

Target

Others, HBV

Related Pathways

Microbiology/Virology, Others

Bioactivity

HBV-IN19 TFA inhibits the secretion and/or production of HBsAg and has an inhibitory effect on hepatitis B virus (HBV) infection and can be used in studies of HBV infection, including chronic HBV infection.

Smiles

OC(=O)C(F)(F)F.[H][C@]12CCC(C)(C)N1n1cc(C(O)=O)c(=O)cc1-c1cc(COC)c(OCCCOC)cc21

Molecular Formula

C26H31F3N2O8

Molecular Weight

556.53

Shipping Conditions

Ice Packs

Storage Temperature

-20°C

Related Products

Catalog	Name
T62579-01	HBV-IN-19
T83682-01	Tat-Gap 19 TFA
T76044-01	Elabela (19-32) TFA
T76008-01	Protein Kinase C (19-31) (TFA)
TP1109-01	Tirzepatide TFA (2023788-19-2 free base)
TP1314-01	AMARA peptide TFA (163560-19-8 free base)
T209597-01	HBV-IN-45
T63795-01	HBV-IN-6
T62144-01	HBV-IN-13
T36747-01	HBV-IN-4

Alternative Products

Catalog	Name
GTR19186019-01	HBV-IN-19
MBS5806602	HBV-IN-19 TFA
ant-150	HBV
P525235	HBV-C Protein (C-His, HBV)
LV1601	HBV(+) and HBV(-) noncancerous liver tissue array
BA1849-10	HBV-IN-37
FSD89784-01	HBV-IN-4
601090020	Truenat™ HBV
HY-146395	HBV-IN-23
HY-149435	HBV-IN-36

HBV-IN-19 TFA

Related Products

Alternative Products

Popular Products